Latest from Tuberous Sclerosis Alliance

The partnership will combine 2 databases with robust historical data in hopes of empowering both research and physician communities and ultimately improving clinical care for patients with tuberous sclerosis complex. 
The Tuberous Sclerosis Alliance (TS Alliance) have prepared an FAQ to address concerns from the tuberous sclerosis complex (TSC) community regarding the COVID-19 outbreak. 
The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.
The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years. 
The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex. 
SAP Partner Banner